Errors in Figure 2 and Table 2 Footnotes

In the Original Investigation titled “Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere)” published in February 2023 in JAMA Dermatology,¹ there were errors in Figure 2 and some of the footnotes in Table 2. Some of the time points and significance levels in Figure 2 and the statistical analysis note in Table 2 were corrected. This article was corrected online.